Form 8-K - Current report:
SEC Accession No. 0000078003-24-000144
Filing Date
2024-07-26
Accepted
2024-07-26 11:09:20
Documents
18
Period of Report
2024-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PFIZER 8-K JULY 24 2024 pfe-20240724.htm   iXBRL 8-K 44479
2 EX-99.1 tsruex991.htm EX-99.1 8262
3 EX-99.2 psasex9922.htm EX-99.2 9803
8 GRAPHIC pfizerlogo7-25.jpg GRAPHIC 11034
9 GRAPHIC pfizerlogo7-251.jpg GRAPHIC 11034
  Complete submission text file 0000078003-24-000144.txt   267263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240724.xsd EX-101.SCH 2737
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240724_def.xml EX-101.DEF 15360
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240724_lab.xml EX-101.LAB 27449
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240724_pre.xml EX-101.PRE 16027
20 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240724_htm.xml XML 4272
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 241144546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)